Literature DB >> 11600500

Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors.

M Ogris1, R C Carlisle, T Bettinger, L W Seymour.   

Abstract

Entry of exogenously applied DNA into the cytoplasm and subsequent transport into the nucleus are major cellular barriers for nonviral gene delivery vectors. To overcome these barriers, we have covalently attached the cationic peptide melittin to poly(ethylenimine) (PEI). This conjugate condensed DNA into small, discrete particles (<100 nm in diameter), and the membrane lytic activity of melittin enabled efficient release of the DNA into the cytoplasm, as monitored by fluorescence microscopy and flow cytometry. Compared with PEI, the transfection activity was strongly increased within a broad range of cell lines and types tested, including different tumor cell lines but also primary hepatocytes and human umbilical vein endothelial cells. The early onset of gene expression (within 4 h, reaching maximal values after 12 h) and the high reporter gene expression achieved in slowly dividing or confluent cells suggested a further role of melittin after releasing the DNA into the cytoplasm. Intracytoplasmic microinjection of melittin-containing PEI.DNA complexes into fibroblasts produced 40% cellular frequency of reporter gene expression that was inhibitable by co-injection of wheat germ agglutinin, whereas simple PEI.DNA complexes showed only 10%. These data suggest that melittin enables release of nonviral gene transfer particles into the cytoplasm and also enhances their transport into the nucleus, possibly via the cationic cluster KRKR near the C terminus of the peptide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600500     DOI: 10.1074/jbc.M108331200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery.

Authors:  Nathan P Gabrielson; Hua Lu; Lichen Yin; Dong Li; Fei Wang; Jianjun Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-07       Impact factor: 15.336

2.  Efficient active transport of gene nanocarriers to the cell nucleus.

Authors:  Junghae Suh; Denis Wirtz; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

Review 3.  Improvement of DNA transfection with cationic liposomes.

Authors:  A Rocha; S Ruiz; J M Coll
Journal:  J Physiol Biochem       Date:  2002-03       Impact factor: 4.158

4.  Gene transfer with poly-melittin peptides.

Authors:  Chang-Po Chen; Ji-seon Kim; Erin Steenblock; Dijie Liu; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2006 Jul-Aug       Impact factor: 4.774

Review 5.  Nonviral gene delivery: what we know and what is next.

Authors:  Xiang Gao; Keun-Sik Kim; Dexi Liu
Journal:  AAPS J       Date:  2007-03-23       Impact factor: 4.009

Review 6.  Peptide-guided gene delivery.

Authors:  Molly E Martin; Kevin G Rice
Journal:  AAPS J       Date:  2007-02-09       Impact factor: 4.009

7.  Synthetic PEGylated glycoproteins and their utility in gene delivery.

Authors:  Chang-po Chen; Ji-seon Kim; Dijie Liu; Garrett R Rettig; Marie A McAnuff; Molly E Martin; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2007 Mar-Apr       Impact factor: 4.774

Review 8.  Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems.

Authors:  Sabine Boeckle; Ernst Wagner
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

Review 9.  Strategies for improving drug delivery: nanocarriers and microenvironmental priming.

Authors:  Ayesha Khalid; Stefano Persano; Haifa Shen; Yuliang Zhao; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Expert Opin Drug Deliv       Date:  2016-10-11       Impact factor: 6.648

10.  Synthesis and in vitro testing of new potent polyacridine-melittin gene delivery peptides.

Authors:  Nicholas J Baumhover; Kevin Anderson; Christian A Fernandez; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2010-01       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.